| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| TECHBio-Techne Corporation | 10.9B | 69.96 | 152.09 | 5.23% | 6.41% | 3.97% | 2.35% | 0.23 |
| SPRYARS Pharmaceuticals, Inc. | 1.1B | 11.09 | 142.00 | 2970.63% | -56.06% | -54.21% | 1.18% | 0.00 |
| VCYTVeracyte, Inc. | 3.24B | 41.00 | 132.26 | 23.46% | 6.12% | 2.41% | 1.97% | 0.04 |
| CSBRChampions Oncology, Inc. | 99.56M | 7.17 | 21.73 | 13.54% | 4.32% | 59.65% | 7.03% | 1.62 |
| MDXGMiMedx Group, Inc. | 851.59M | 5.75 | 20.54 | 8.52% | 10.38% | 17.09% | 7.58% | 0.13 |
| LTRNLantern Pharma Inc. | 39.26M | 3.51 | -0.00 | -197.36% | 0.01 | |||
| SEERSeer, Inc. | 107.44M | 1.91 | -1.37 | -8.13% | -486.02% | -29.19% | 0.08 | |
| IMDXInsight Molecular Diagnostics Inc. | 189.76M | 6.62 | -1.42 | 25.15% | -13.81% | -14.81% |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 116K | 656K | 6.39M | 14.69M | 15.18M | 13.95M |
| Revenue Growth % | - | - | 4.66% | 8.75% | 1.3% | 0.03% | -0.08% |
| Cost of Goods Sold | 100K | 701K | 1.61M | 6.77M | 14.3M | 13.73M | 7.12M |
| COGS % of Revenue | - | 6.04% | 2.45% | 1.06% | 0.97% | 0.9% | 0.51% |
| Gross Profit | -100K | -585K | -950K | -374K | 384K | 1.45M | 6.83M |
| Gross Margin % | - | -5.04% | -1.45% | -0.06% | 0.03% | 0.1% | 0.49% |
| Gross Profit Growth % | - | -4.85% | -0.62% | 0.61% | 2.03% | 2.77% | 3.71% |
| Operating Expenses | 6.66M | 16.3M | 32.7M | 71.32M | 98.43M | 106.39M | 106.93M |
| OpEx % of Revenue | - | 140.5% | 49.85% | 11.15% | 6.7% | 7.01% | 7.67% |
| Selling, General & Admin | 2.98M | 4.61M | 15.36M | 42.2M | 52.63M | 58.95M | 56.57M |
| SG&A % of Revenue | - | 39.71% | 23.42% | 6.6% | 3.58% | 3.88% | 4.06% |
| Research & Development | 3.68M | 11.69M | 17.34M | 29.12M | 45.8M | 47.44M | 50.59M |
| R&D % of Revenue | - | 100.79% | 26.43% | 4.55% | 3.12% | 3.12% | 3.63% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -223K |
| Operating Income | -6.76M | -16.88M | -33.65M | -71.7M | -98.04M | -104.94M | -100.1M |
| Operating Margin % | - | -145.54% | -51.29% | -11.21% | -6.68% | -6.91% | -7.18% |
| Operating Income Growth % | - | -1.5% | -0.99% | -1.13% | -0.37% | -0.07% | 0.05% |
| EBITDA | -6.66M | -16.18M | -32.04M | -68.13M | -92.14M | -99.36M | -93.92M |
| EBITDA Margin % | - | -139.5% | -48.85% | -10.66% | -6.27% | -6.54% | -6.73% |
| EBITDA Growth % | - | -1.43% | -0.98% | -1.13% | -0.35% | -0.08% | 0.05% |
| D&A (Non-Cash Add-back) | 100K | 701K | 1.61M | 3.56M | 5.9M | 5.58M | 6.18M |
| EBIT | -6.31M | -16.03M | -32.77M | -71.17M | -92.97M | -86.28M | -100.1M |
| Net Interest Income | 451K | 845K | 883K | 304K | 4.6M | 17.76M | 16.67M |
| Interest Income | 451K | 850K | 883K | 326K | 4.6M | 17.76M | 16.67M |
| Interest Expense | 0 | 5K | 0 | 22K | 0 | 0 | 0 |
| Other Income/Expense | 451K | 845K | 874K | 527K | 5.08M | 18.66M | 13.6M |
| Pretax Income | -6.31M | -16.04M | -32.77M | -71.17M | -92.97M | -86.28M | -86.5M |
| Pretax Margin % | - | -138.26% | -49.96% | -11.13% | -6.33% | -5.68% | -6.2% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 98K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -6.31M | -16.04M | -32.77M | -71.17M | -92.97M | -86.28M | -86.6M |
| Net Margin % | - | -138.26% | -49.96% | -11.13% | -6.33% | -5.68% | -6.21% |
| Net Income Growth % | - | -1.54% | -1.04% | -1.17% | -0.31% | 0.07% | -0% |
| Net Income (Continuing) | -6.31M | -16.04M | -32.77M | -71.17M | -92.97M | -86.28M | -86.6M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.29 | -0.26 | -0.51 | -1.13 | -1.42 | -1.35 | -1.39 |
| EPS Growth % | - | 0.1% | -0.96% | -1.22% | -0.26% | 0.05% | -0.03% |
| EPS (Basic) | -0.29 | -0.26 | -0.51 | -1.13 | -1.42 | -1.35 | -1.39 |
| Diluted Shares Outstanding | 21.45M | 60.91M | 60.91M | 60.86M | 62.43M | 63.85M | 62.35M |
| Basic Shares Outstanding | 21.45M | 60.91M | 60.91M | 60.86M | 62.43M | 63.85M | 62.35M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 31.21M | 86.81M | 433.13M | 411.7M | 434.98M | 330.51M | 253.32M |
| Cash & Short-Term Investments | 30.95M | 86.02M | 431.86M | 400.07M | 421.24M | 316.22M | 236.41M |
| Cash Only | 30.95M | 17.48M | 333.58M | 232.81M | 53.21M | 32.5M | 40.75M |
| Short-Term Investments | 0 | 68.53M | 98.28M | 167.26M | 368.03M | 283.73M | 195.66M |
| Accounts Receivable | 69K | 326K | 262K | 4.14M | 7.02M | 6.72M | 6.23M |
| Days Sales Outstanding | - | 1.03K | 145.78 | 236.56 | 174.43 | 161.46 | 163.02 |
| Inventory | 0 | 0 | 551K | 4.14M | 4.63M | 4.49M | 7.44M |
| Days Inventory Outstanding | - | - | 125.23 | 223.54 | 118.09 | 119.36 | 381.47 |
| Other Current Assets | 0 | 0 | 452K | 0 | 2.1M | 3.08M | 3.25M |
| Total Non-Current Assets | 2.48M | 6.43M | 9.19M | 127.44M | 52.95M | 105.76M | 113.27M |
| Property, Plant & Equipment | 2.36M | 5.69M | 8.44M | 33.23M | 46.41M | 47.37M | 41.37M |
| Fixed Asset Turnover | - | 0.02x | 0.08x | 0.19x | 0.32x | 0.32x | 0.34x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 343K | 93.19M | 5.16M | 56.86M | 63.1M |
| Other Non-Current Assets | 124K | 743K | 407K | 1.02M | 1.38M | 1.53M | 8.8M |
| Total Assets | 33.7M | 93.24M | 442.32M | 539.14M | 487.93M | 436.27M | 366.6M |
| Asset Turnover | - | 0.00x | 0.00x | 0.01x | 0.03x | 0.03x | 0.04x |
| Asset Growth % | - | 1.77% | 3.74% | 0.22% | -0.09% | -0.11% | -0.16% |
| Total Current Liabilities | 3.69M | 3.81M | 8.09M | 13.42M | 12.58M | 13.22M | 15.33M |
| Accounts Payable | 2.63M | 701K | 2.12M | 3.79M | 2.1M | 1.37M | 4.62M |
| Days Payables Outstanding | 9.58K | 365 | 480.68 | 204.34 | 53.7 | 36.41 | 237.06 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 2.29M | 2.31M |
| Deferred Revenue (Current) | 0 | 175K | 250K | 376K | 133K | 206K | 408K |
| Other Current Liabilities | 344K | 1.6M | 2.86M | 4.73M | 6.35M | 2.73M | 1.54M |
| Current Ratio | 8.46x | 22.75x | 53.51x | 30.67x | 34.57x | 25.00x | 16.53x |
| Quick Ratio | 8.46x | 22.75x | 53.44x | 30.36x | 34.20x | 24.66x | 16.04x |
| Cash Conversion Cycle | - | - | -209.68 | 255.76 | 238.83 | 244.41 | 307.43 |
| Total Non-Current Liabilities | 30K | 1.74M | 2.62M | 22.8M | 28.35M | 26.14M | 23.7M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 22.46M | 28.03M | 25.96M | 23.65M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 30K | 1.74M | 2.62M | 341K | 320K | 179K | 48K |
| Total Liabilities | 3.72M | 5.56M | 10.71M | 36.22M | 40.94M | 39.37M | 39.03M |
| Total Debt | 0 | 0 | 0 | 23.32M | 29.87M | 28.26M | 25.96M |
| Net Debt | -30.95M | -17.48M | -333.58M | -209.49M | -23.33M | -4.24M | -14.79M |
| Debt / Equity | - | - | - | 0.05x | 0.07x | 0.07x | 0.08x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | - | -3376.60x | - | -3258.91x | - | - | - |
| Total Equity | 29.98M | 87.68M | 431.61M | 502.92M | 446.99M | 396.9M | 327.57M |
| Equity Growth % | - | 1.93% | 3.92% | 0.17% | -0.11% | -0.11% | -0.17% |
| Book Value per Share | 1.40 | 1.44 | 7.09 | 8.26 | 7.16 | 6.22 | 5.25 |
| Total Shareholders' Equity | 29.98M | 87.68M | 431.61M | 502.92M | 446.99M | 396.9M | 327.57M |
| Common Stock | 0 | 0 | 1K | 1K | 1K | 1K | 1K |
| Retained Earnings | -6.55M | -22.59M | -55.36M | -126.53M | -219.5M | -305.77M | -392.37M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -31K | 24K | 54K | -536K | -1.25M | -192K | 136K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -4.65M | -13.07M | -20.83M | -46.35M | -60.78M | -59.06M | -46.11M |
| Operating CF Margin % | - | -112.7% | -31.75% | -7.25% | -4.14% | -3.89% | -3.31% |
| Operating CF Growth % | - | -1.81% | -0.59% | -1.23% | -0.31% | 0.03% | 0.22% |
| Net Income | -6.31M | -16.04M | -32.77M | -71.17M | -92.97M | -86.28M | -86.6M |
| Depreciation & Amortization | 31K | 701K | 1.61M | 2.56M | 3.94M | 5.58M | 6.18M |
| Stock-Based Compensation | 672K | 1.56M | 7.35M | 25.93M | 33.67M | 34.42M | 28.21M |
| Deferred Taxes | 0 | -259K | 0 | 1.2M | 0 | 0 | 0 |
| Other Non-Cash Items | 549K | 5K | 271K | 1M | 1.66M | -10.07M | 6.25M |
| Working Capital Changes | 953K | 961K | 2.72M | -5.87M | -7.09M | -2.72M | -144K |
| Change in Receivables | -69K | -257K | 64K | -2.5M | -2.87M | 302K | 487K |
| Change in Inventory | 0 | 257K | -551K | -3.59M | -1.59M | -1.95M | -2.67M |
| Change in Payables | 323K | 218K | 912K | 1.6M | -1.55M | -987K | 3.35M |
| Cash from Investing | -168K | -72.38M | -34.56M | -170.88M | -122.72M | 37.9M | 65.86M |
| Capital Expenditures | -168K | -4.13M | -4.53M | -6.92M | -10.27M | -7.31M | -3.58M |
| CapEx % of Revenue | - | 35.61% | 6.91% | 1.08% | 0.7% | 0.48% | 0.26% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | -68.25M | 0 | -163.96M | 170K | 0 | 343K |
| Cash from Financing | 29.95M | 72.33M | 371.49M | 116.63M | 3.89M | 452K | -11.49M |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | 29.95M | 406K | 1.26M | 13.71M | 3.91M | 465K | 321K |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | -4.82M | -17.2M | -25.36M | -53.27M | -71.05M | -66.37M | -49.69M |
| FCF Margin % | - | -148.31% | -38.66% | -8.33% | -4.84% | -4.37% | -3.56% |
| FCF Growth % | - | -2.57% | -0.47% | -1.1% | -0.33% | 0.07% | 0.25% |
| FCF per Share | -0.22 | -0.28 | -0.42 | -0.88 | -1.14 | -1.04 | -0.80 |
| FCF Conversion (FCF/Net Income) | 0.74x | 0.82x | 0.64x | 0.65x | 0.65x | 0.68x | 0.53x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 645K | 232K | 0 | 154K |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -21.04% | -27.26% | -12.62% | -15.23% | -19.57% | -20.45% | -23.91% |
| Return on Invested Capital (ROIC) | - | -36.59% | -30% | -27.47% | -20.51% | -19.28% | -21.28% |
| Gross Margin | - | -504.31% | -144.82% | -5.85% | 2.61% | 9.54% | 48.99% |
| Net Margin | - | -13825.86% | -4996.19% | -1113.06% | -633.07% | -568.28% | -620.91% |
| Debt / Equity | - | - | - | 0.05x | 0.07x | 0.07x | 0.08x |
| Interest Coverage | - | -3376.60x | - | -3258.91x | - | - | - |
| FCF Conversion | 0.74x | 0.82x | 0.64x | 0.65x | 0.65x | 0.68x | 0.53x |
| Revenue Growth | - | - | 465.52% | 874.7% | 129.67% | 3.38% | -8.13% |
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Grant | 223K | - | 1.1M |
| Grant Growth | - | - | - |
| Product | 3.58M | 8.56M | - |
| Product Growth | - | 139.22% | - |
| Related Party | 2.32M | 5.21M | - |
| Related Party Growth | - | 125.08% | - |
| Service | 500K | 913K | - |
| Service Growth | - | 82.60% | - |
| Grant and Other | - | 808K | - |
| Grant and Other Growth | - | - | - |
Seer, Inc. (SEER) reported $16.3M in revenue for fiscal year 2024.
Seer, Inc. (SEER) saw revenue decline by 8.1% over the past year.
Seer, Inc. (SEER) reported a net loss of $79.3M for fiscal year 2024.
Seer, Inc. (SEER) has a return on equity (ROE) of -23.9%. Negative ROE indicates the company is unprofitable.
Seer, Inc. (SEER) had negative free cash flow of $46.1M in fiscal year 2024, likely due to heavy capital investments.